Research

Energy balance

Systematic measurement of sexual desire should be prioritized in future research on GLP-1 agonists.

Researchers should include sexual desire as a key outcome in studies involving GLP-1 agonists.

StrongSupportsmedium confidence
Future research should prioritize longitudinal studies to assess changes in sexual desire among individuals prescribed GLP-1 agonists.
Sergei Gelfand et al. · Obesity Pillars · 2025

Why this rating

The claim is based on a narrative review analysis of existing literature.

Source

Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don’t ‘see’ it

Sergei Gelfand et al. · Obesity Pillars · 2025

DOI 10.1016/j.obpill.2025.100233

reviewCited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →